Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, June 28 '25)

Image
By G.M.

 


    Antimicrob Agents Chemother

  1. MENG X, Zhang C, Wang X, Shi J, et al
    A branched peptide targets virus and host to block influenza virus and rhinovirus entry.
    Antimicrob Agents Chemother. 2025 Jun 25:e0002425. doi: 10.1128/aac.00024.
    PubMed         Abstract available


    Antiviral Res

  2. HUSSAIN S, Meijer A, Govorkova EA, Dapat C, et al
    Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.
    Antiviral Res. 2025 Jun 24:106217. doi: 10.1016/j.antiviral.2025.106217.
    PubMed         Abstract available


    Biochemistry

  3. PANKRATOVA Y, Hong M
    Side Chain Structures of the Proton-Selective Histidine and Gating Tryptophan in Influenza BM2 Reveal Both Conservation and Variation of the Proton Conduction Mechanism.
    Biochemistry. 2025 Jun 24. doi: 10.1021/acs.biochem.5c00242.
    PubMed         Abstract available


    Cell

  4. DHENNI R, Hoppe AC, Reynaldi A, Kyaw W, et al
    Macrophages direct location-dependent recall of B cell memory to vaccination.
    Cell. 2025;188:3477-3496.
    PubMed         Abstract available


    Epidemiol Infect

  5. COLEMAN BL, Robertson NM, Harrison RA, Valiquette L, et al
    Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.
    Epidemiol Infect. 2025;153:e72.
    PubMed         Abstract available


    J Infect

  6. RIVERA-IZQUIERDO M, Verdejo-Ianez A, Morales-Portillo A, Gonzalez-Alcaide M, et al
    High-dose versus standard-dose influenza vaccine for immunocompromised patients: A systematic review and meta-analysis of randomised clinical trials.
    J Infect. 2025;91:106538.
    PubMed         Abstract available

  7. WANG J, Guo S, Zhao J, Sun T, et al
    Host lncRNA assists the nuclear import of influenza A virus protein PB2 in a species-specific manner.
    J Infect. 2025;91:106540.
    PubMed         Abstract available

  8. YANG J, Chen X, Li X, Zhang Y, et al
    Global spread of H3 subtype avian influenza viruses with an accelerated evolution after interspecies transmission.
    J Infect. 2025 Jun 20:106542. doi: 10.1016/j.jinf.2025.106542.
    PubMed         Abstract available


    J Infect Dis

  9. GUILFOYLE K, Mirolo M, de Waal L, van Amerongen G, et al
    Highly Pathogenic Avian Influenza Virus A/H5N1 subclade 2.3.4.4 b isolated from a European grey seal (Halichoerus grypus) is highly virulent in ferrets.
    J Infect Dis. 2025 Jun 28:jiaf348. doi: 10.1093.
    PubMed         Abstract available

  10. LU Y, Allen JD, Ross TM, Cowling B, et al
    Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge Trial.
    J Infect Dis. 2025 Jun 20:jiaf331. doi: 10.1093.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  11. DIAZ MH, Hersh AL, Olson J, Shah SS, et al
    Mycoplasma pneumoniae Infections in Hospitalized Children - United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:394-400.
    PubMed         Abstract available


    PLoS Biol

  12. YIN X, Pu Y, Yuan S, Pache L, et al
    Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection.
    PLoS Biol. 2025;23:e3002738.
    PubMed         Abstract available


    PLoS Comput Biol

  13. GAZEAU ST, Deng X, Brunet-Ratnasingham E, Kaufmann DE, et al
    Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.
    PLoS Comput Biol. 2025;21:e1013170.
    PubMed         Abstract available

  14. VOUTOURI C, Munn LL, Stylianopoulos T, Jain RK, et al
    Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactions.
    PLoS Comput Biol. 2025;21:e1013163.
    PubMed         Abstract available

  15. DEICHMANN J, Barda N, Canetti M, Peretz Y, et al
    Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data.
    PLoS Comput Biol. 2025;21:e1013192.
    PubMed         Abstract available


    PLoS One

  16. PITOL AK, Venkatesan S, Richards S, Hoptroff M, et al
    SARS-CoV-2 survival on skin and its transfer from contaminated surfaces.
    PLoS One. 2025;20:e0325235.
    PubMed         Abstract available

  17. FISH LE, Roberts SC, Bennett TD, Carlson NE, et al
    Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment.
    PLoS One. 2025;20:e0325991.
    PubMed         Abstract available

  18. RUSSELL S, Munro K, Foulkes S, Broad J, et al
    Adapting COVID-19 research infrastructure to capture influenza and RSV alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Evaluation of the SIREN Winter Pressures pilot study.
    PLoS One. 2025;20:e0310758.
    PubMed         Abstract available

  19. ZHU L, Zhong L, Huang G
    Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0326777.
    PubMed         Abstract available

  20. LUNDA O, Chauke L, Daef G, Olorunfemi G, et al
    Maternal deaths before and during COVID-19 pandemic: Causes and avoidable factors in a tertiary hospital in South Africa, 2018?2022.
    PLoS One. 2025;20:e0326424.
    PubMed         Abstract available

  21. MURPHY J, Livings MS, Wong M, Huang J, et al
    The association between community solidarity and adoption of public health preventive measures during the COVID-19 pandemic in a cross-sectional, multi-national sample.
    PLoS One. 2025;20:e0324234.
    PubMed         Abstract available

  22. VALLEE G, Xi D, Avramovic G, O'Kelly B, et al
    Evaluating the longitudinal physical and psychological health effects of persistent long Covid 3.5 years after infection.
    PLoS One. 2025;20:e0326790.
    PubMed         Abstract available

  23. ZEBARDAST A, Sadeghi K, Nejati A, Zadheidar S, et al
    A targeted approach for multiplex detection of respiratory viruses in cases with severe acute respiratory infections by nanopore sequencing.
    PLoS One. 2025;20:e0324601.
    PubMed         Abstract available

  24. MANCHEL A, Erdemir A, Mulugeta L, Ku JP, et al
    A rubric for assessing conformance to the Ten Rules for credible practice of modeling and simulation in healthcare.
    PLoS One. 2025;20:e0313711.
    PubMed         Abstract available

  25. DEMIRKIRAN B, Isin A, Sungur Y, Melekoglu T, et al
    The impact of 8-week re-training following a 14-week period of training cessation on Greco-Roman Wrestlers.
    PLoS One. 2025;20:e0326731.
    PubMed         Abstract available

  26. AMELINE AS, Chandra DN, Htet MK, Zahra NL, et al
    Prevalence and factors associated with anemia among pregnant women during the COVID-19 pandemic in East Lombok district, Indonesia.
    PLoS One. 2025;20:e0323942.
    PubMed         Abstract available

  27. AQEEL I, Majid A, Alahmadi TJ, Althubaity A, et al
    In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19.
    PLoS One. 2025;20:e0325707.
    PubMed         Abstract available

  28. WHARTON E, O'Brien T, Foster RJ, Giebel C, et al
    "I don't know if it makes a difference to safety?" perception vs actuality: A mixed-methods study on older adults' experiences of home stair falls revealed during COVID-19 lockdown.
    PLoS One. 2025;20:e0326850.
    PubMed         Abstract available

  29. AUNG KT, Htun YM, Htet ZL, Soe YNM, et al
    Parental hesitancy on COVID-19 vaccination of children under the age of 16: A cross-sectional mixed-methods study among factory workers.
    PLoS One. 2025;20:e0327056.
    PubMed         Abstract available

  30. NGUYEN QT, Nguyen MPN, Bui NY, Ngo MQ, et al
    The complex interplay of personal and external factors in medical students' specialty decision-making: A qualitative study.
    PLoS One. 2025;20:e0326932.
    PubMed         Abstract available

  31. OLARTE L, Lee B, Banerjee D, Swanson DS, et al
    Pneumococcal colonization dynamics among young children with and without respiratory symptoms during the first year of the SARS-CoV-2 pandemic.
    PLoS One. 2025;20:e0327046.
    PubMed         Abstract available

  32. JEONG JY, Jeong YM
    Health behavior and mental health by gender in Korean adults before, during, and after the COVID-19 pandemic.
    PLoS One. 2025;20:e0325895.
    PubMed         Abstract available

  33. BEKUMA TT, Seme A, Ahmed S, Abera M, et al
    Level and determinants of pentavalent vaccine dropout during infancy: A hierarchical analysis of community-level longitudinal study.
    PLoS One. 2025;20:e0326684.
    PubMed         Abstract available

  34. VERLY-MIGUEL M, Lopes CS, Freitas JV, Garcia MC, et al
    Depression, anxiety and change in eating habits during the COVID-19 pandemic in Brazilian university students.
    PLoS One. 2025;20:e0326856.
    PubMed         Abstract available

  35. AL SUFIAN SHUVO A, Maekawa Y, Kassai M, Kawahara T, et al
    Inhibitory effects of a hot-water extract of cumin fruit on influenza A virus infection.
    PLoS One. 2025;20:e0326423.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  36. JURASZEK J, Kadam RU, Branduardi D, van Ameijde J, et al
    De novo design of D-peptide ligands: Application to influenza virus hemagglutinin.
    Proc Natl Acad Sci U S A. 2025;122:e2426554122.
    PubMed         Abstract available

  37. GUTMANN T, Kuster D, Hyman AA
    SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.
    Proc Natl Acad Sci U S A. 2025;122:e2426204122.
    PubMed         Abstract available


    Vaccine

  38. SONG Z, Ma Y, Jiao L, Yu R, et al
    Lovastatin enhanced immune response to avian influenza vaccine in chickens and changed mRNA expression in the bursa of fabricius.
    Vaccine. 2025;61:127438.
    PubMed         Abstract available

  39. SHINJOH M, Tamura K, Yamaguchi Y, Fukushima H, et al
    Influenza vaccination in Japanese children, 2024/25: Effectiveness of inactivated vaccine and limited use of newly introduced live-attenuated vaccine.
    Vaccine. 2025;61:127429.
    PubMed         Abstract available

  40. SAMY A, Alber A, Fife M, Hammond JA, et al
    IFITM knockout DF1 cells produce higher influenza and newcastle disease viral yields: a proof of concept for avian origin cell-based vaccine production.
    Vaccine. 2025;61:127360.
    PubMed         Abstract available

  41. MISHINA M, Cao W, Ende Z, Sharma SS, et al
    Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel.
    Vaccine. 2025;61:127361.
    PubMed         Abstract available


    Virology

  42. BRUNO A, de Mora D, Olmedo M, Garces J, et al
    Highly pathogenic avian influenza A (H5N1) virus outbreaks in South America in 2022-2024: a comprehensive review of an ongoing panzootic.
    Virology. 2025;610:110602.
    PubMed         Abstract available

  43. NGUYEN XD, Le B, Yang Q, Wang B, et al
    PathoSift Pro: A novel size-based bioaerosol sampler for effectively detecting infectious airborne influenza virus.
    Virology. 2025;610:110609.
    PubMed         Abstract available

  44. PASQUALE S, Moscara L, Palmieri C, Martinelli A, et al
    Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024.
    Virology. 2025;610:110613.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

Stability of #influenza viruses in the #milk of #cows and #sheep

By G.M.
Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...
Post a Comment
Read more »

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

By G.M.
Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____
Post a Comment
Read more »